Mefloquine Market

Mefloquine Market Size, Share & Industry Analysis, By Application (Treatment of Malaria, Malaria Prophylaxis, Off-label Use in Treating Babesiosis, Research Studies on the Neuropsychiatric Side Effects of Antimalarials, Combination Therapy Formulations), By Source (Synthetic Organic Pathway, Chemical Synthesis, Enzymatic Synthesis, In-house Production), Key End-Use Industry (Pharmaceutical Companies, Military & Defense Health Services, Travel Medicine Clinics, Research & Academic Institutes, Government & International Health Organizations), and Forecast, 2025–2035

​The Mefloquine market is projected to grow steadily from 2025 to 2035, at a CAGR of 3.9%. Growth is primarily driven by rising demand for antimalarial drugs, increasing global travel to endemic regions, and continued use by military healthcare systems. Mefloquine remains a critical pharmaceutical agent for Plasmodium falciparum treatment and malaria prophylaxis.

Regionally, North America dominates the Mefloquine market owing to established pharmaceutical infrastructure, government stockpiling for defense purposes, and approvals for travel-related malaria treatments. Certainly, the Asia-Pacific is the fastest-growing region, driven by a rising malaria burden, growing public health spending, and expanding local API manufacturing capabilities.

The market report highlights innovations in synthesis pathways to improve purity, reduce adverse effects, and enable inclusion in fixed-dose combinations. Challenges include competition from newer antimalarial therapies, neuropsychiatric safety concerns, and regulatory hurdles in some regions. Nonetheless, growing global health initiatives and consistent need for effective prophylaxis are expected to support stable market expansion.

Seeking Comprehensive Intelligence on Different markets? Get in Touch with our Experts

Report Scope & Segmentation

  1. Introduction
  • Overview of Mefloquine
  • Key Applications & Industry Use Cases
  • Market Scope & Study Objectives
  1. Market Overview
  • Global Market Size & Growth Trends (Historical & Forecast)
  • Market Value & Revenue Analysis
  • Demand-Supply Dynamics
  1. Segmental Outlook
  • By Application
    • Treatment of Malaria
    • Malaria Prophylaxis
    • Off-label use in treating Babesiosis
    • Research studies on the neuropsychiatric side effects of antimalarials
    • Combination therapy formulations
  • By Source
    • Synthetic Organic Pathway
    • Chemical Synthesis
    • Enzymatic Synthesis
    • In-house Production
  • Key End-Use Industry
    • Pharmaceutical Companies
    • Military & Defense Health Services
    • Travel Medicine Clinics
    • Research & Academic Institutes
    • Government & International Health Organizations

 

  1. Price Analysis
  • Current Price Trends (Per kg & Per Ton)
  • Price Fluctuation Factors (Raw Material Costs, Production, Trade Tariffs)
  • Regional Price Comparison (North America, Europe, Asia-Pacific, and Other)
  1. Production & Supply Volume
  • Global Production Capacity & Key Manufacturers
  • Production Process & Technological Developments
  • Raw Material Analysis
  1. Trade Analysis (Import & Export)
  • Major Exporting & Importing Countries
  • Trade Volume & Value Statistics
  • Impact of Trade Regulations & Policies
  1. Regional Analysis
  • North America (US and Canada)
  • Europe (UK, Germany, France, Italy, Spain, and the Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, Taiwan, India, and Rest of Asia-Pacific)
  • Rest of the World (Latin America and Middle East and Africa)
  1. Competitive Landscape
  • Top Global Manufacturers & Market Share
  • Company Profiles & Key Developments
  • Mergers, Acquisitions & Investments
  1. Regulatory & Compliance Factors
  • FDA, REACH, and Other Regulatory Frameworks
  • Environmental & Safety Considerations
  • Emerging Policies Impacting Market Growth
  1. Conclusion & Strategic Recommendations
  • Key Takeaways for Stakeholders
  • Market Entry Strategies
What is Mefloquine?
Mefloquine is a synthetic antimalarial agent primarily used for the treatment and prevention of malaria caused by Plasmodium falciparum. It is known for its long half-life and is effective in regions with drug-resistant strains.
What is the market size for Mefloquine?
The Mefloquine market is projected to grow at a CAGR of 3.9% from 2025 to 2035. The market is driven by demand in malaria-endemic regions and use in travel and military medicine. While specific revenue figures vary, steady growth is expected due to continued global health needs.
What are the drivers for the Mefloquine market?
Key drivers include the persistent prevalence of malaria in tropical regions and rising international travel to endemic areas. Government programs and military healthcare systems significantly contribute to consistent demand. Additionally, ongoing research into improving drug formulations supports market growth.
Who are the key players operating in the Mefloquine market?
Major players include Cipla Ltd., Ipca Laboratories, Teva Pharmaceutical Industries Ltd., Zydus Lifesciences, Merck KGaA, Unichem Laboratories, and Mangalam Drugs & Organics Ltd.
Which region is expected to exhibit the fastest growth in the Mefloquine market?
The Asia-Pacific region is expected to exhibit the fastest growth in the Mefloquine market during the forecast period. This is attributed to high malaria incidence, improving healthcare infrastructure, and growing pharmaceutical manufacturing capacity.
$1800/- Single User License
$3600/- Multi User License

How can we help you?

Reach out to discuss how our team can help your business achieve real results.